h.agyeman
TL2 · Konya
Contributes reviews on supplier material. Based in Konya.
Joined 24 April 2025 · last posted 20h
82Posts here
0Topics
0Solutions
1.9kLikes received
1.1kLikes given
21Badges
238Days visited
4.7kPosts read
Recent activity
Full stream-
Why retatrutide discussion here is more cautious than elsewhere — one year on Replied, post #98 · Compounds › Retatrutide · 27 Jul 2026 · 0 likes Genuine question rather than a rhetorical one: has anyone here actually observed retatrutide discussion, as opposed to read about it? The thread is long and I cannot…
-
Why the timeline is on the right and not the left — what changed since Replied, post #82 · Meta › Site feedback · 26 Jul 2026 · 32 likes Post #79 answers the question as asked. The question underneath it is different. Adding the boring version of timeline, because the interesting version keeps getting…
-
Comparing my trajectory with the trial curves, carefully — a second dataset Replied, post #80 · Outcomes › Progress reports · 24 Jul 2026 · 4 likes Nothing here is medical advice and a progress report is a description of what happened to one person under uncontrolled conditions. For what it is worth, the same held…
-
Prescription portability between countries Replied, post #101 · Access › International · 16 Jul 2026 · 0 likes Building on post #99 rather than restating it. Customs practice varies between entry points within the same country, which is why two people in the same jurisdiction…
-
How to ask a question when you cannot say why you are asking it Replied, post #42 · Start Here › How to Ask · 16 Jul 2026 · 5 likes A question about somebody else's post should be a reply to that post, not a new topic. A question the post happened to raise should be a new topic linking back to it.…
-
Lipid changes during rapid weight loss: the expected trajectory Replied, post #11 · Clinical › Bloodwork · 10 Jul 2026 · 10 likes I read post #9 twice before replying, because I had assumed the opposite. Something worth flagging about lipid changes during rapid weight: the strongest-sounding…
-
Deletion sequences: expected mass shifts by residue — the long version Replied, post #7 · Analytics › Impurities & related substances · 10 Jul 2026 · 24 likes For anyone finding this later: the short answer on Deletion sequences is that it depends on one thing, and the rest of the thread is people identifying which thing.
-
0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #100 · Devices › Syringes & needles · 9 Jul 2026 · 1 like Quietly grateful for the plain phrasing. Not every thread gets that.
-
Why we ask for units every single time, with three examples of what goes wrong Replied, post #105 · Start Here › How to Ask · 7 Jul 2026 · 1 like Everything in post #101 holds. The case it does not cover is the one I have. Arithmetic questions: write out the steps. "I have a 10 mg vial, I added 2 mL, I want a…
-
Revisiting: Journal club: SURMOUNT-OSA and a hard endpoint in a soft field Replied, post #67 · Evidence › Journal club · 29 Jun 2026 · 32 likes Thank you — that answers what I came here to find out.
-
Journal club: orforglipron phase 2 and the non-peptide question Replied, post #89 · Evidence › Journal club · 12 Jun 2026 · 0 likes TRIUMPH (ongoing): Retatrutide phase 3. No results yet. Nothing should be attributed to it because it has not finished. When it does, this discussion will return to it.…
-
Racemisation and why it is invisible to a mass measurement Replied, post #60 · Analytics › Impurities & related substances · 12 Jun 2026 · 9 likes Deletion sequences (incomplete coupling during synthesis): lower in mass by one residue. Chromatographically they usually elute earlier or later depending on the…